A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors

被引：0
|
作者：
Jessica Castrillon Lal
Sherry-Ann Brown
Patrick Collier
Feixiong Cheng
机构：
[1] Genomic Medicine Institute,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine
[2] Lerner Research Institute,Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic
[3] Cleveland Clinic,Case Comprehensive Cancer Center
[4] Case Western Reserve University,undefined
[5] Cardio-Oncology Program,undefined
[6] Division of Cardiovascular Medicine,undefined
[7] Medical College of Wisconsin,undefined
[8] Sydell and Arnold Miller Family Heart and Vascular Institute,undefined
[9] Case Western Reserve University School of Medicine,undefined
来源：
Cardio-Oncology | / 7卷
关键词：
Cardio-oncology; Cardiotoxicity; Immune checkpoint inhibitors; Immunotherapy; Myocardial infarction; Myocarditis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study
    Tan, S.
    Spear, E.
    Sane, N.
    Chan, J.
    Nelson, A. J.
    Nerlekar, N.
    Segelov, E.
    Nicholls, S. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [22] Advances on immune-related adverse events associated with immune checkpoint inhibitors
    Yong Fan
    Yan Geng
    Lin Shen
    Zhuoli Zhang
    Frontiers of Medicine, 2021, 15 : 33 - 42
  • [23] Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
    Gan, Linyang
    Chen, Huan
    Liu, Xiaowei
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] Advances on immune-related adverse events associated with immune checkpoint inhibitors
    Yong Fan
    Yan Geng
    Lin Shen
    Zhuoli Zhang
    Frontiers of Medicine, 2021, 15 (01) : 33 - 42
  • [25] Advances on immune-related adverse events associated with immune checkpoint inhibitors
    Fan, Yong
    Geng, Yan
    Shen, Lin
    Zhang, Zhuoli
    FRONTIERS OF MEDICINE, 2021, 15 (01) : 33 - 42
  • [26] Immune Checkpoint Inhibitors and the Risk of Cardiovascular Adverse Events: A Pooled Clinical Trial Database Analysis
    Ports, Kayleen
    Jain, Rahul
    Diamond, Sheila
    Aptekar, Jacob
    Fajgenbaum, David C.
    BLOOD, 2023, 142
  • [27] Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
    Astaras, Christophoros
    de Micheli, Rita
    Moura, Bianca
    Hundsberger, Thomas
    Hottinger, Andreas F.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (01)
  • [28] Peripheral nervous system adverse events associated with immune checkpoint inhibitors
    Rossi, Simone
    Gelsomino, Francesco
    Rinaldi, Rita
    Muccioli, Lorenzo
    Comito, Francesca
    Di Federico, Alessandro
    De Giglio, Andrea
    Lamberti, Giuseppe
    Andrini, Elisa
    Mollica, Veronica
    D'Angelo, Roberto
    Baccari, Flavia
    Zenesini, Corrado
    Madia, Pierandrea
    Raschi, Emanuel
    Cortelli, Pietro
    Ardizzoni, Andrea
    Guarino, Maria
    JOURNAL OF NEUROLOGY, 2023, 270 (06) : 2975 - 2986
  • [29] Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews
    Kanji, Salmaan
    Morin, Sydney
    Agtarap, Kyla
    Purkayastha, Debanjali
    Thabet, Pierre
    Bosse, Dominick
    Wang, Xiang
    Lunny, Carole
    Hutton, Brian
    DRUGS, 2022, 82 (07) : 793 - 809
  • [30] Common endocrine system adverse events associated with immune checkpoint inhibitors☆
    Li, Ying
    Zhao, Junfeng
    Wang, Yue
    Xu, Yali
    Li, Ruyue
    Zhao, Ying
    Dong, Xue
    Yao, Xiujing
    Li, Yintao
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (03): : 164 - 172
12345